Mexico

BMI View: Multinational drugmakers are increasingly seeking expansion in Latin America to reduce their dependence on the slow-growing markets in Europe and the US. The region's two... 2012-01-17

BMI View: Mexico's pharmaceutical market has many fundamental characteristics that are attracting drugmakers, including relatively high urbanisation, a significant chronic disease burden... 2012-01-12

BMI View: When pharmaceutical companies enter a new market they should make sure their products fit the market needs and tailor their strategic endeavours to avoid unnecessary costs,... 2012-01-06

BMI Core View: Drugmakers based in emerging markets will expand their presence in developed countries. Firms in developing countries enjoy low operating costs but have historically... 2011-12-05

BMI View: Although we view the government's efforts to roll out universal healthcare coverage favourably, Mexico will continue to show signs of being a patchwork healthcare system unless... 2011-12-01

BMI View: Just months after Mexico's government initiated a nation-wide crackdown on over-the-counter (OTC) medicines, it seems pressure from pharmaceutical manufacturers and pharmacy... 2011-11-11

BMI View: Bucking a global push towards over-the-counter (OTC) medicines, governments across Latin America have responded to a series of scandals by clamping down on pharmacy sales.... 2011-10-28